Reyon Pharmaceutical Co Ltd (102460.KS) Key Developments |
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Sadif Analytics Prime
Provider : Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Reyon Pharmaceutical Co Ltd announces change in shareholding structure

Tuesday, 12 Aug 2014 10:58pm EDT 

Reyon Pharmaceutical Co Ltd:Jeong Soon Ok and seven related parties is holding 71.21 pct stake (9,185,730 shares) in the company, as inheritance from Yoo Sung Rak. 

Company Quote

450.0 +1.36%
1 Jul 2016